Lipoprotein dynamics in neuromyelitis optica spectrum disorder

Area of Science:

• Neuroimmunology
• Lipidomics
• Biomarker Discovery

Background:

• Neuromyelitis optica spectrum disorder (NMOSD) is a severe neuroinflammatory condition.
• The role of dyslipidemia in NMOSD disease activity is not well understood.
• Altered lipid profiles are noted in other neuroinflammatory diseases.

Purpose of the Study:

• To investigate plasma lipoprotein profiles in NMOSD patients.
• To identify potential lipid biomarkers for NMOSD disease activity.
• To explore the relationship between lipid profiles and disease severity.

Main Methods:

• Analyzed plasma lipoprotein components in 40 NMOSD patients during relapse.
• Compared profiles with 35 multiple sclerosis (MS) patients and 41 healthy controls (HCs).
• Utilized receiver operating characteristic (ROC) analysis for biomarker identification and correlated levels with clinical data.

Main Results:

• 39 out of 112 lipoprotein components were significantly altered in NMOSD patients compared to MS and HCs.
• Lower levels of specific lipoproteins (e.g., Apo-A2, HDL-3-Apo-A2, VLDL-3-PLs) were observed during NMOSD relapses.
• HDL-4-Apo-A2 levels negatively correlated with disability and spinal cord lesion length in NMOSD patients.

Conclusions:

• NMOSD exhibits unique dyslipidemia patterns associated with disease activity.
• Lipoprotein profiling shows potential as a noninvasive prognostic biomarker for NMOSD.
• Lipid profiles normalized during remission, indicating a dynamic relationship with disease state.